Farther Finance Advisors LLC Buys New Shares in Tempus AI, Inc. (NASDAQ:TEM)

Farther Finance Advisors LLC purchased a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,000 shares of the company’s stock, valued at approximately $34,000.

Other large investors have also recently bought and sold shares of the company. First Horizon Advisors Inc. acquired a new position in shares of Tempus AI during the 3rd quarter worth about $30,000. FNY Investment Advisers LLC bought a new position in Tempus AI during the fourth quarter worth about $67,000. IFP Advisors Inc acquired a new position in Tempus AI during the fourth quarter worth approximately $76,000. US Bancorp DE bought a new stake in Tempus AI in the fourth quarter valued at approximately $80,000. Finally, Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Tempus AI in the fourth quarter valued at approximately $178,000. 24.22% of the stock is owned by institutional investors and hedge funds.

Tempus AI Trading Up 14.9 %

Shares of NASDAQ:TEM opened at $59.00 on Tuesday. Tempus AI, Inc. has a one year low of $22.89 and a one year high of $91.45. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The firm has a 50 day simple moving average of $56.88 and a 200 day simple moving average of $51.40.

Insider Transactions at Tempus AI

In other news, EVP Andrew Polovin sold 13,135 shares of Tempus AI stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $45.98, for a total transaction of $603,947.30. Following the sale, the executive vice president now directly owns 154,171 shares of the company’s stock, valued at approximately $7,088,782.58. This trade represents a 7.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Ryan Fukushima sold 20,000 shares of the business’s stock in a transaction dated Tuesday, January 7th. The stock was sold at an average price of $39.61, for a total value of $792,200.00. Following the sale, the chief operating officer now owns 982,442 shares in the company, valued at approximately $38,914,527.62. This trade represents a 2.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 5,598,969 shares of company stock worth $317,194,162.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. Guggenheim restated a “buy” rating on shares of Tempus AI in a research note on Tuesday, February 25th. William Blair reiterated a “market perform” rating on shares of Tempus AI in a report on Tuesday, February 25th. TD Cowen reaffirmed a “buy” rating and set a $74.00 target price (up previously from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th. JPMorgan Chase & Co. cut shares of Tempus AI from an “overweight” rating to a “neutral” rating and increased their price target for the company from $50.00 to $55.00 in a report on Tuesday, February 25th. Finally, Bank of America boosted their price objective on Tempus AI from $54.00 to $60.00 and gave the stock a “neutral” rating in a report on Monday, March 3rd. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, Tempus AI presently has a consensus rating of “Moderate Buy” and a consensus target price of $61.18.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.